Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Risk Estimation in Breast Cancer and Assessing Health Disparities

NCT05755269 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05755269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05755269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Risk Estimation in Breast Cancer and Assessing Health Disparities
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Terminated
Start date
March 14, 2023
Completion date
December 31, 2025
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast atypical ductal hyperplasia, breast atypical lobular hyperplasia, breast carcinoma, breast lobular carcinoma in situ